Use access key #2 to skip to page content.
$48.64 -3.65 (-6.98%)
10/6/2008 4:04 PM

Novo Nordisk A/S (ADR) (NVO)

CAPS Rating:
****

Engaged in discovery, development, manufacturing and marketing of pharmaceutical products and has two business segments - diabetes care and biopharmaceuticals.

View All Commentary (NVO)

Recs

3

Avatar xthecritic (36.33) Submitted: 12/17/07 2:17 PM : Outperform Start Price: $52.39 NVO Score: 12.19

This is a sector play. Drug manufacturers have been and will continue to outperform the market in the next 12-18 months as we deal with economic weakness. I like the sector overall after several years of pressure from products coming off patent and with positive overall demographic trends.

Novo Nordisk is a market leader in diabetes care - already huge and still growing market.

Report this Post Replies: 0 | Reply

Featured Broker Partners